SCHEMBL19398451

SCHEMBL19398451

CCCCCCO[C@@H]1OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O[C@H]3OC(CO)[C@H](O)[C@H](O[C@@H]4OC(CO)[C@H](O)[C@H](O[C@@H]5OC(CO)[C@H](O)[C@H](O)C5O[C@@H]5OC(CO)[C@@H](O)[C@H](O)C5O)C4NC(C)=O)C3O)[C@H](O)C2O)[C@H](O)C1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGALS8 O00214 2/20 0.66
LGALS3 P17931 2/20 0.66
LGALS4 P56470 2/20 0.66
MAPK1 P28482 1/20 0.65
CD209 Q9NNX6 2/20 0.48
ENGASE Q8NFI3 1/20 0.47
BMP2 P12643 2/20 0.46
VEGFA P15692 2/20 0.46
CXCL12 P48061 2/20 0.46
SHH Q15465 2/20 0.46
SELP P16109 2/20 0.46
IFNG P01579 1/20 0.46
PF4 P02776 1/20 0.46
CCL2 P13500 1/20 0.46
BMP6 P22004 1/20 0.46
CCL11 P51671 1/20 0.46
WNT3A P56704 1/20 0.46
SELPLG Q14242 1/20 0.46
GJB2 P29033 1/20 0.46
PTN P21246 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19398453 0.96 LGALS8 (0.61) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19398454 0.93 LGALS8 (0.59) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19398452 0.92 LGALS3 (0.57) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19398446 0.92 LGALS8 (0.57) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19398457 0.92 LGALS8 (0.65) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19404388 0.92 LGALS8 (0.65) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19404390 0.92 LGALS8 (0.65) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL15081918 0.92 LGALS3 (0.69) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL10106219 0.92 LGALS3 (0.69) LGALS8LGALS3LGALS4MAPK1CD209
SCHEMBL19404689 0.90 LGALS8 (0.61) LGALS8LGALS3LGALS4MAPK1CD209

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275389-A1 NOVEL GLYCAN CONJUGATES AND USE THEREOF ACADEMIA SINICA (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275389-A1 NOVEL GLYCAN CONJUGATES AND USE THEREOF STT3B, ST3GAL3, FUT6 LGALS8 28/4885LGALS3 43/4885LGALS4 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.